HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Liability Issues Could Arise Under Personal Care Products Safety Act

This article was originally published in The Rose Sheet

Executive Summary

The draft Personal Care Products Safety Act’s safety substantiation requirements – including statements from responsible persons attesting to product safety – are hazily defined and could pose liability risks, in addition to burdens for small companies in particular, EAS consultant John Bailey says. For these reasons and others, the former FDAer is skeptical that industry will support the bill in its current form.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel